Axsome Therapeutics
AXSM
AXSM
111 hedge funds and large institutions have $387M invested in Axsome Therapeutics in 2019 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 46 increasing their positions, 24 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.14% less ownership
Funds ownership: 55.11% → 54.97% (-0.14%)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
19% less capital invested
Capital invested by funds: $476M → $387M (-$89.2M)
Holders
111
Holding in Top 10
5
Calls
$29.4M
Puts
$16.2M
Top Buyers
| 1 | +$8.1M | |
| 2 | +$4.92M | |
| 3 | +$4.26M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$4.13M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$3.24M |
Top Sellers
| 1 | -$13.7M | |
| 2 | -$9.86M | |
| 3 | -$6.37M | |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$3.54M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$3.38M |